Jump to content


Advertisement

Photo

Link to FDA Briefing Document


  • Please log in to reply
No replies to this topic

#1 GailSusan

GailSusan

    Very Prolific Member

  • Members
  • PipPipPipPip
  • 1,808 posts
  • City:USA

Posted 19 June 2001 - 01:47 AM

Advertisement
http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3627b1a.pdf This is a 94 page document that can only be read using Adobe Acrobat reader. It is the briefing document Novartis submitted to the FDA as part of the drug approval process. It explains the results of the Phase 2 & 3 clinical trials and safety issues.------------------***Gail
"It is the dull man who is always sure, and the sure man who is always dull." H.L. Mencken


Advertisement




Advertisement


About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service

Irritable Bowel Syndrome |  Inflammatory Bowel Disease |  Crohn's Disease |  Ulcerative Colitis |  Fibromyalgia |  GERD - Reflux Disease


©Copyright 1995-2013 All rights reserved IBS Self Help and Support Group

Website Monitoring by: AlertBot



This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here